Immune System Diseases Unknown Status Phase Trials for Ocrelizumab (DB11988)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03344094Mechanism of Action of Ocrelizumab in Multiple Sclerosis